An Open Labeled Phase 2 Study of Gemcitabine in Combination With Cisplatin, 5-FU (24h CI) and Folinic Acid in Patients With Inoperable Esophageal Cancer.

Trial Profile

An Open Labeled Phase 2 Study of Gemcitabine in Combination With Cisplatin, 5-FU (24h CI) and Folinic Acid in Patients With Inoperable Esophageal Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Oct 2008

At a glance

  • Drugs Cisplatin; Fluorouracil; Folinic acid; Gemcitabine
  • Indications Oesophageal cancer
  • Focus Therapeutic Use
  • Acronyms CONKO-101
  • Most Recent Events

    • 08 Oct 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top